ADVENT Forum 2022 | Exploring Features in Type 2 Inflammation

• Describe the evolution of type 2 inflammation from protection to pathology
• Examine the shared and distinct roles of type 2 inflammatory mediators in the pathology of diseases with underlying type 2 inflammation
• Highlight the importance of a multidisciplinary approach and shared decision-making in the patient-centered care in type 2 inflammatory diseases
• Evaluate the latest clinical data for biologics in atopic dermatitis and in asthma in pediatric patients

Join Klaus Rabe, MD, PhD; Lisa Beck, MD, PhD; and Joaquim Mullol, MD, PhD; as they highlight the evolution of type 2 inflammation from protection to pathology, and the core processes of type 2 inflammation and commonalities across type 2 inflammatory diseases including (but not limited to) barrier disruption, microbiome changes, tissue remodeling, and neuroimmune dysfunction.